12 Best Depressed Stocks to Buy in 2025

8. Novo Nordisk A/S (NYSE:NVO)

52 Week Range: $45.57-$139.74

Current Share Price: $46.10

Stock Upside Potential: 58.35%

Market Cap: $154.57 Billion

Number of Hedge Fund Holders: 60

Novo Nordisk A/S (NYSE:NVO) is one of the best depressed stocks to buy in 2025. On August 4, the company confirmed it had received an unsolicited mini-tender offer from TRC Capital Investment Corporation.

The mini tender offer is for the purchase of up to 2 million American Depositary shares representing less than 0.045% of its total share capital. Novo Nordisk management remains neutral in the tender offer and has advised shareholders to exercise caution and consult financial advisors.

Given that the tender offer covers an immaterial stake, there will be no change in Novo Nordisk’s control or capital structure.

Novo Nordisk A/S (NYSE:NVO) is a healthcare company that develops and delivers innovative treatments for serious chronic diseases, with a particular emphasis on diabetes and obesity. It also develops treatments for rare blood and endocrine diseases, haemophilia, and growth disorders.